Prior approval requirements in the US healthcare industry represent an annual cost of approximately $35 billion. The overuse of these requirements is causing discontent and has prompted politicians to react. The article deals with expectations in the area of prior authorization in 2026. It focuses on potential changes and their impact on the health care system. The aim is to examine whether the proposed changes will actually lead to an improvement in the prior approval process.